0.022121
0.000000
0.010851
0.000000
0.019398
0.000000
0.000000
0.000000
0.024474
0.00000
0.00000
0.00000
Brinen, L.S.
Gillmor, S.A.
Fletterick, R.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
2
90.00
116.13
90.00
45.206
51.551
45.511
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
C34 H36 N2 O6 S
600.724
N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER
WRR-204
peptide-like
To be Published
0353
Crystal Structure of Cruzain bound to WRR-204
University of California, San Francisco (THESIS)
Enzyme-ligand Interactions, Inhibition and Specificity
50
80
Chapter 3: X-ray Structures of Complexes of Cruzain with Designed Covalent Inhibitors
1998
US
Protein Sci.
PRCIEI
0795
0961-8368
6
1603
1611
Structural Determinants of Specificity in the Cysteine Protease Cruzain
1997
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
247
251
259
10.1006/jmbi.1994.0137
The Crystal Structure of Cruzain: a Therapeutic Target for Chagas' Disease
1995
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
298
1
IMAGE PLATE
1997-10-14
RIGAKU RAXIS IV
SINGLE WAVELENGTH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RU200
22715.133
CRUZAIN
3.4.22.-
CATALYTIC DOMAIN
1
man
polymer
600.724
N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER
1
syn
non-polymer
18.015
water
38
nat
water
CRUZIPAIN, cruzaine
no
no
APAAVDWRARGAVTAVKDQGQCGSCWAFSAIGNVECQWFLAGHPLTNLSEQMLVSCDKTDSGCSGGLMNNAFEWIVQENN
GAVYTEDSYPYASGEGISPPCTTSGHTVGATITGHVELPQDEAQIAAWLAVNGPVAVAVDASSWMTYTGGVMTSCVSEQL
DHGVLLVGYNDSAAVPYWIIKNSWTTQWGEEGYIRIAKGSNQCLVKEEASSAVVG
APAAVDWRARGAVTAVKDQGQCGSCWAFSAIGNVECQWFLAGHPLTNLSEQMLVSCDKTDSGCSGGLMNNAFEWIVQENN
GAVYTEDSYPYASGEGISPPCTTSGHTVGATITGHVELPQDEAQIAAWLAVNGPVAVAVDASSWMTYTGGVMTSCVSEQL
DHGVLLVGYNDSAAVPYWIIKNSWTTQWGEEGYIRIAKGSNQCLVKEEASSAVVG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Trypanosoma
Escherichia
sample
5693
Trypanosoma cruzi
562
Escherichia coli
DH5ALPHA
CHEY
1
2.10
41.29
VAPOR DIFFUSION, HANGING DROP
7.0
0.8M NaCitrate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K
292
repository
Initial release
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Version format compliance
1
0
2003-06-10
1
1
2008-04-27
1
2
2011-07-13
same protein, ZYA inhibitor
same protein, ZRA inhibitor
same protein, WRR-99 inhibitor
same protein, WRR-112 inhibitor
same protein, MOR-LEU-HPQ inhibitor
RCSB
Y
RCSB
2000-04-26
REL
REL
VSC
N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER
HOH
water
VSC WAS N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-
5-PHENYL-PENT-1-ENE-1-SULFONIC ACID PHENYL ESTER BEFORE
REACTION WITH THE PROTEASE. AFTER REACTION, THE SG OF
CYS 25 IS LINKED TO C32 OF THE VSC 280,
N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-
PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER. THE
PHENYL RING ATTACHED TO ONE OXYGEN OF THE SULFONIC
ACID PORTION OF THE LIGAND IS MISSING IN THE DENSITY.
THERE IS A STOP CODON AFTER RESIDUE 212.
VSC
280
2
VSC
VSC
280
A
WAT
1
3
HOH
HOH
281
A
WAT
2
3
HOH
HOH
282
A
WAT
3
3
HOH
HOH
283
A
WAT
4
3
HOH
HOH
284
A
WAT
5
3
HOH
HOH
285
A
WAT
6
3
HOH
HOH
286
A
WAT
7
3
HOH
HOH
287
A
WAT
8
3
HOH
HOH
288
A
WAT
9
3
HOH
HOH
289
A
WAT
10
3
HOH
HOH
290
A
WAT
11
3
HOH
HOH
291
A
WAT
12
3
HOH
HOH
292
A
WAT
13
3
HOH
HOH
293
A
WAT
14
3
HOH
HOH
294
A
WAT
15
3
HOH
HOH
295
A
WAT
16
3
HOH
HOH
296
A
WAT
17
3
HOH
HOH
297
A
WAT
18
3
HOH
HOH
298
A
WAT
19
3
HOH
HOH
299
A
WAT
20
3
HOH
HOH
300
A
WAT
21
3
HOH
HOH
301
A
WAT
22
3
HOH
HOH
302
A
WAT
23
3
HOH
HOH
303
A
WAT
24
3
HOH
HOH
304
A
WAT
25
3
HOH
HOH
305
A
WAT
26
3
HOH
HOH
306
A
WAT
27
3
HOH
HOH
307
A
WAT
28
3
HOH
HOH
308
A
WAT
29
3
HOH
HOH
309
A
WAT
30
3
HOH
HOH
310
A
WAT
31
3
HOH
HOH
311
A
WAT
32
3
HOH
HOH
312
A
WAT
33
3
HOH
HOH
313
A
WAT
34
3
HOH
HOH
314
A
WAT
35
3
HOH
HOH
315
A
WAT
36
3
HOH
HOH
316
A
WAT
37
3
HOH
HOH
317
A
WAT
38
3
HOH
HOH
318
A
ALA
1
n
1
ALA
1
A
PRO
2
n
2
PRO
2
A
ALA
3
n
3
ALA
3
A
ALA
4
n
4
ALA
4
A
VAL
5
n
5
VAL
5
A
ASP
6
n
6
ASP
6
A
TRP
7
n
7
TRP
7
A
ARG
8
n
8
ARG
8
A
ALA
9
n
9
ALA
9
A
ARG
10
n
10
ARG
10
A
GLY
11
n
11
GLY
11
A
ALA
12
n
12
ALA
12
A
VAL
13
n
13
VAL
13
A
THR
14
n
14
THR
14
A
ALA
15
n
15
ALA
15
A
VAL
16
n
16
VAL
16
A
LYS
17
n
17
LYS
17
A
ASP
18
n
18
ASP
18
A
GLN
19
n
19
GLN
19
A
GLY
20
n
20
GLY
20
A
GLN
21
n
21
GLN
21
A
CYS
22
n
22
CYS
22
A
GLY
23
n
23
GLY
23
A
SER
24
n
24
SER
24
A
CYS
25
n
25
CYS
25
A
TRP
26
n
26
TRP
26
A
ALA
27
n
27
ALA
27
A
PHE
28
n
28
PHE
28
A
SER
29
n
29
SER
29
A
ALA
30
n
30
ALA
30
A
ILE
31
n
31
ILE
31
A
GLY
32
n
32
GLY
32
A
ASN
33
n
33
ASN
33
A
VAL
34
n
34
VAL
34
A
GLU
35
n
35
GLU
35
A
CYS
36
n
36
CYS
36
A
GLN
37
n
37
GLN
37
A
TRP
38
n
38
TRP
38
A
PHE
39
n
39
PHE
39
A
LEU
40
n
40
LEU
40
A
ALA
41
n
41
ALA
41
A
GLY
42
n
42
GLY
42
A
HIS
43
n
43
HIS
43
A
PRO
44
n
44
PRO
44
A
LEU
45
n
45
LEU
45
A
THR
46
n
46
THR
46
A
ASN
47
n
47
ASN
47
A
LEU
48
n
48
LEU
48
A
SER
49
n
49
SER
49
A
GLU
50
n
50
GLU
50
A
GLN
51
n
51
GLN
51
A
MET
52
n
52
MET
52
A
LEU
53
n
53
LEU
53
A
VAL
54
n
54
VAL
54
A
SER
55
n
55
SER
55
A
CYS
56
n
56
CYS
56
A
ASP
57
n
57
ASP
57
A
LYS
58
n
58
LYS
58
A
THR
59
n
59
THR
59
A
ASP
60
n
60
ASP
60
A
SER
61
n
61
SER
61
A
GLY
62
n
62
GLY
62
A
CYS
63
n
63
CYS
63
A
SER
64
n
64
SER
64
A
GLY
65
n
65
GLY
65
A
GLY
66
n
66
GLY
66
A
LEU
67
n
67
LEU
67
A
MET
68
n
68
MET
68
A
ASN
69
n
69
ASN
69
A
ASN
70
n
70
ASN
70
A
ALA
71
n
71
ALA
71
A
PHE
72
n
72
PHE
72
A
GLU
73
n
73
GLU
73
A
TRP
74
n
74
TRP
74
A
ILE
75
n
75
ILE
75
A
VAL
76
n
76
VAL
76
A
GLN
77
n
77
GLN
77
A
GLU
78
n
78
GLU
78
A
ASN
78
n
79
A
ASN
78
A
ASN
78
n
80
B
ASN
78
A
GLY
78
n
81
C
GLY
78
A
ALA
79
n
82
ALA
79
A
VAL
80
n
83
VAL
80
A
TYR
81
n
84
TYR
81
A
THR
82
n
85
THR
82
A
GLU
83
n
86
GLU
83
A
ASP
84
n
87
ASP
84
A
SER
85
n
88
SER
85
A
TYR
86
n
89
TYR
86
A
PRO
87
n
90
PRO
87
A
TYR
88
n
91
TYR
88
A
ALA
89
n
92
ALA
89
A
SER
89
n
93
A
SER
89
A
GLY
89
n
94
B
GLY
89
A
GLU
89
n
95
C
GLU
89
A
GLY
90
n
96
GLY
90
A
ILE
91
n
97
ILE
91
A
SER
92
n
98
SER
92
A
PRO
93
n
99
PRO
93
A
PRO
94
n
100
PRO
94
A
CYS
95
n
101
CYS
95
A
THR
96
n
102
THR
96
A
THR
97
n
103
THR
97
A
SER
98
n
104
SER
98
A
GLY
99
n
105
GLY
99
A
HIS
100
n
106
HIS
100
A
THR
101
n
107
THR
101
A
VAL
102
n
108
VAL
102
A
GLY
103
n
109
GLY
103
A
ALA
105
n
110
ALA
105
A
THR
106
n
111
THR
106
A
ILE
107
n
112
ILE
107
A
THR
108
n
113
THR
108
A
GLY
109
n
114
GLY
109
A
HIS
110
n
115
HIS
110
A
VAL
111
n
116
VAL
111
A
GLU
112
n
117
GLU
112
A
LEU
113
n
118
LEU
113
A
PRO
114
n
119
PRO
114
A
GLN
115
n
120
GLN
115
A
ASP
116
n
121
ASP
116
A
GLU
117
n
122
GLU
117
A
ALA
118
n
123
ALA
118
A
GLN
119
n
124
GLN
119
A
ILE
120
n
125
ILE
120
A
ALA
121
n
126
ALA
121
A
ALA
122
n
127
ALA
122
A
TRP
123
n
128
TRP
123
A
LEU
124
n
129
LEU
124
A
ALA
125
n
130
ALA
125
A
VAL
126
n
131
VAL
126
A
ASN
127
n
132
ASN
127
A
GLY
128
n
133
GLY
128
A
PRO
129
n
134
PRO
129
A
VAL
130
n
135
VAL
130
A
ALA
131
n
136
ALA
131
A
VAL
132
n
137
VAL
132
A
ALA
133
n
138
ALA
133
A
VAL
134
n
139
VAL
134
A
ASP
135
n
140
ASP
135
A
ALA
136
n
141
ALA
136
A
SER
139
n
142
SER
139
A
SER
140
n
143
SER
140
A
TRP
141
n
144
TRP
141
A
MET
142
n
145
MET
142
A
THR
143
n
146
THR
143
A
TYR
144
n
147
TYR
144
A
THR
145
n
148
THR
145
A
GLY
146
n
149
GLY
146
A
GLY
147
n
150
GLY
147
A
VAL
148
n
151
VAL
148
A
MET
149
n
152
MET
149
A
THR
151
n
153
THR
151
A
SER
152
n
154
SER
152
A
CYS
153
n
155
CYS
153
A
VAL
154
n
156
VAL
154
A
SER
155
n
157
SER
155
A
GLU
156
n
158
GLU
156
A
GLN
156
n
159
A
GLN
156
A
LEU
157
n
160
LEU
157
A
ASP
158
n
161
ASP
158
A
HIS
159
n
162
HIS
159
A
GLY
160
n
163
GLY
160
A
VAL
161
n
164
VAL
161
A
LEU
162
n
165
LEU
162
A
LEU
163
n
166
LEU
163
A
VAL
164
n
167
VAL
164
A
GLY
165
n
168
GLY
165
A
TYR
166
n
169
TYR
166
A
ASN
167
n
170
ASN
167
A
ASP
167
n
171
A
ASP
167
A
SER
167
n
172
B
SER
167
A
ALA
167
n
173
C
ALA
167
A
ALA
167
n
174
D
ALA
167
A
VAL
168
n
175
VAL
168
A
PRO
169
n
176
PRO
169
A
TYR
170
n
177
TYR
170
A
TRP
171
n
178
TRP
171
A
ILE
172
n
179
ILE
172
A
ILE
173
n
180
ILE
173
A
LYS
174
n
181
LYS
174
A
ASN
175
n
182
ASN
175
A
SER
176
n
183
SER
176
A
TRP
177
n
184
TRP
177
A
THR
178
n
185
THR
178
A
THR
179
n
186
THR
179
A
GLN
180
n
187
GLN
180
A
TRP
181
n
188
TRP
181
A
GLY
182
n
189
GLY
182
A
GLU
183
n
190
GLU
183
A
GLU
184
n
191
GLU
184
A
GLY
185
n
192
GLY
185
A
TYR
186
n
193
TYR
186
A
ILE
187
n
194
ILE
187
A
ARG
188
n
195
ARG
188
A
ILE
189
n
196
ILE
189
A
ALA
190
n
197
ALA
190
A
LYS
191
n
198
LYS
191
A
GLY
192
n
199
GLY
192
A
SER
193
n
200
SER
193
A
ASN
198
n
201
ASN
198
A
GLN
199
n
202
GLN
199
A
CYS
200
n
203
CYS
200
A
LEU
201
n
204
LEU
201
A
VAL
202
n
205
VAL
202
A
LYS
203
n
206
LYS
203
A
GLU
204
n
207
GLU
204
A
GLU
205
n
208
GLU
205
A
ALA
206
n
209
ALA
206
A
SER
207
n
210
SER
207
A
SER
208
n
211
SER
208
A
ALA
209
n
212
ALA
209
A
VAL
210
n
213
VAL
210
A
VAL
211
n
214
VAL
211
A
GLY
212
n
215
GLY
212
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
VAL
111
A
N
VAL
116
A
O
SER
208
A
O
SER
211
A
O
SER
207
A
O
SER
210
A
N
ALA
131
A
N
ALA
136
A
N
VAL
134
A
N
VAL
139
A
O
HIS
159
A
O
HIS
162
A
O
TYR
166
A
O
TYR
169
A
N
VAL
5
A
N
VAL
5
A
N
VAL
111
A
N
VAL
116
A
O
SER
208
A
O
SER
211
A
O
SER
207
A
O
SER
210
A
N
ALA
131
A
N
ALA
136
A
N
VAL
134
A
N
VAL
139
A
O
HIS
159
A
O
HIS
162
A
N
ASN
167
A
N
ASN
170
A
O
TYR
170
A
O
TYR
177
A
N
ILE
173
A
N
ILE
180
A
O
ILE
187
A
O
ILE
194
A
O
ARG
188
A
O
ARG
195
A
N
MET
149
A
N
MET
152
A
O
VAL
80
A
O
VAL
83
A
N
GLY
103
A
N
GLY
109
1
A
C36
VSC
280
B
C36
VSC
1
1
N
1
A
C37
VSC
280
B
C37
VSC
1
1
N
1
A
C38
VSC
280
B
C38
VSC
1
1
N
1
A
C39
VSC
280
B
C39
VSC
1
1
N
1
A
C40
VSC
280
B
C40
VSC
1
1
N
1
A
C41
VSC
280
B
C41
VSC
1
1
N
1
A
ASP
57
-68.81
94.96
1
A
ALA
89
-141.44
28.59
1
A
SER
155
-118.55
79.19
1
A
GLU
156
-121.31
-54.50
1
A
ASP
158
-150.55
7.77
1
A
THR
178
74.63
162.15
1
A
CYS
200
59.33
18.66
PARHCSDX.PRO
TOPHCSDX.PRO
PARAM19.SOL
TOPH19.SOL
VSC.TPX
VSC_VER2.TPX
19.9
0.00
0.00
0.00
0.00
0.00
0.00
parameters for VSC from moloc
0.262
0.008
0.221
0.23
0.221
2.10
30.00
1033
10544
10544
9.8
95.0
RANDOM
10000000.00
0.00
1
RESTRAINED
THROUGHOUT
0.0
0
Engh & Huber
0.34
0.28
5.00
0.40
0.32
2.10
30.00
38
1668
37
0
1593
0.005
1.2
25.0
1.04
0.355
0.028
0.298
2.23
166
1522
6
9.8
91.9
7.2
2.1
30
1EWO
10544
10544
0
-3.0
0.077
1
7.2
2.1
92.2
0.197
2.10
2.18
997
1
2.1
90.6
data reduction
DENZO
data scaling
SCALEPACK
phasing
AMoRE
refinement
X-PLOR
3.843
CRUZAIN (E.C.3.4.22.-)
THE CYSTEINE PROTEASE CRUZAIN BOUND TO WRR-204
1
N
N
2
N
N
3
N
N
A
ARG
8
A
ARG
8
HELX_P
A
GLY
11
A
GLY
11
5
1
4
A
SER
24
A
SER
24
HELX_P
A
ALA
41
A
ALA
41
1
2
18
A
SER
49
A
SER
49
HELX_P
A
ASP
57
A
ASP
57
1
3
9
A
SER
61
A
SER
61
HELX_P
A
GLY
65
A
GLY
65
5
4
5
A
ASP
116
A
ASP
121
HELX_P
A
GLY
128
A
GLY
133
1
6
13
A
ALA
136
A
ALA
141
HELX_P
A
TYR
144
A
TYR
147
5
7
7
A
ASN
198
A
ASN
201
HELX_P
A
VAL
202
A
VAL
205
5
8
5
disulf
2.029
A
CYS
22
A
SG
CYS
22
1_555
A
CYS
63
A
SG
CYS
63
1_555
disulf
2.028
A
CYS
56
A
SG
CYS
56
1_555
A
CYS
95
A
SG
CYS
101
1_555
disulf
2.029
A
CYS
153
A
SG
CYS
155
1_555
A
CYS
200
A
SG
CYS
203
1_555
covale
1.823
A
CYS
25
A
SG
CYS
25
1_555
A
VSC
280
B
C32
VSC
1_555
HYDROLASE/HYDROLASE INHIBITOR
cysteine protease, drug design, covalent inhibitor, cruzipain, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
CYSP_TRYCR
UNP
1
123
P25779
APAAVDWRARGAVTAVKDQGQCGSCWAFSAIGNVECQWFLAGHPLTNLSEQMLVSCDKTDSGCSGGLMNNAFEWIVQENN
GAVYTEDSYPYASGEGISPPCTTSGHTVGATITGHVELPQDEAQIAAWLAVNGPVAVAVDASSWMTYTGGVMTSCVSEQL
DHGVLLVGYNDSAAVPYWIIKNSWTTQWGEEGYIRIAKGSNQCLVKEEASSAVVG
123
337
1EWO
1
212
P25779
A
1
1
215
5
7
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
A
GLY
109
A
GLY
114
A
GLU
112
A
GLU
117
A
ALA
206
A
ALA
209
A
VAL
210
A
VAL
213
A
VAL
130
A
VAL
135
A
VAL
134
A
VAL
139
A
HIS
159
A
HIS
162
A
ASN
167
A
ASN
170
A
ALA
4
A
ALA
4
A
ASP
6
A
ASP
6
A
GLY
109
A
GLY
114
A
GLU
112
A
GLU
117
A
ALA
206
A
ALA
209
A
VAL
210
A
VAL
213
A
VAL
130
A
VAL
135
A
VAL
134
A
VAL
139
A
HIS
159
A
HIS
162
A
ASN
167
A
ASN
170
A
TYR
170
A
TYR
177
A
LYS
174
A
LYS
181
A
TYR
186
A
TYR
193
A
ALA
190
A
ALA
197
A
VAL
148
A
VAL
151
A
MET
149
A
MET
152
A
ALA
79
A
ALA
82
A
TYR
81
A
TYR
84
A
VAL
102
A
VAL
108
A
THR
106
A
THR
111
BINDING SITE FOR RESIDUE VSC A 280
Software
12
A
GLN
19
A
GLN
19
12
1_555
A
GLY
23
A
GLY
23
12
1_555
A
CYS
25
A
CYS
25
12
1_555
A
TRP
26
A
TRP
26
12
1_555
A
SER
61
A
SER
61
12
1_555
A
CYS
63
A
CYS
63
12
1_555
A
GLY
65
A
GLY
65
12
1_555
A
GLY
66
A
GLY
66
12
1_555
A
ALA
133
A
ALA
138
12
1_555
A
ASP
158
A
ASP
161
12
1_555
A
HIS
159
A
HIS
162
12
1_555
A
TRP
177
A
TRP
184
12
1_555
4
P 1 21 1